共 103 条
[1]
Messina JP(2015)Global distribution and prevalence of hepatitis C virus genotypes Hepatology 61 77-87
[2]
Humphreys I(2012)Natural history of acute and chronic hepatitis C Best Pract Res Clin Gastroenterol 26 401-412
[3]
Flaxman A(2015)Screening for hepatitis C JAMA 313 1855-1856
[4]
Maasoumy B(2015)Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence Liver Int 35 2433-2441
[5]
Wedemeyer H(2011)Incidence and transmission patterns of acute hepatitis C in the United States, 1982–2006 Arch Internal Med 171 242-248
[6]
Wray CM(2015)Interferon-free combination therapies for the treatment of hepatitis C: current insights Hepatic Med Evid Res 7 51-70
[7]
Davis AM(2013)Ever closer to a prophylactic vaccine for HCV Expert Opin Biol Therapy 13 1109-1124
[8]
Dhanasekaran R(2014)EASL Clinical Practice Guidelines: management of hepatitis C virus infection J Hepatol 60 392-420
[9]
Sanchez W(2013)25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end Nat Rev Immunol 13 535-542
[10]
Mounajjed T(2011)Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C Nat Rev Gastroenterol Hepatol 8 212-223